If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

An Investigation of Nebulized Bronchodilator Delivery Using a Pediatric Lung Model of Spontaneous Breathing

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.


BACKGROUND: The literature lacks comparative data on nebulizer aerosol delivered via mask versus T-piece, to spontaneously breathing pediatric subjects. PURPOSE: To compare total inhaled drug mass delivered via standard pediatric aerosol mask versus via T-piece, with increasing distance. METHODS: We used a sample of 5 nebulizers, operated under manufacturers' conditions, with a standard pediatric aerosol mask and with a T-piece capped at one end, at 0 cm, 1 cm, and 2 cm from an inhalation filter placed at the inlet of a pediatric test lung. Inhaled drug mass was analyzed with spectrophotometry. Aerosol particle size was measured separately from the breathing simulations, using a laser particle sizer to determine fine-particle mass (particles < 4.7 μm) and fine-particle fraction as percent of total mass. The fine-particle fraction was used to estimate the fine-particle mass. RESULTS: The mean ± SD values for inhaled drug mass as a percentage of nominal dose, at 0 cm, 1 cm, and 2 cm, with the mask were 2.88 ± 0.79%, 1.61 ± 0.65%, and 1.3 ± 0.42%, respectively, and with the T-piece were 4.14 ± 1.37%, 3.77 ± 1.04%, and 3.47 ± 0.64%, respectively. There was a statistically greater inhaled drug mass with T-piece than with mask, overall (p < 0.01), and a significant decrease with mask or T-piece as distance increased (p < 0.01). The difference between mask and T-piece for inhaled drug mass at 2 cm was statistically significant (p < 0.018). The mean ± SD values for fine-particle mass estimated as a percentage of total drug mass at 0, 1, and 2 cm, with the mask were 1.39 ± 0.36%, 0.78 ± 0.29%, and 0.64 ± 0.20%, respectively, and with the T-piece were 2.1 ± 0.63%, 1.84 ± 0.45%, and 1.71 ± 0.27%, respectively. CONCLUSION: Inhaled drug mass was greater with T-piece than with a standard pediatric aerosol mask under the conditions studied.


Document Type: Research Article

Affiliations: 1: Department of Respiratory Care, University of Texas Health Science Center at San Antonio, 7703 Floyd C Drive, Mail Code 6248, San Antonio TX 78229-3900;, Email: restrepor@uthscsa.edu.edu 2: Cardiac Intensive Care Unit, Children's Health Care of Atlanta at Egleston, Atlanta, Georgia 3: Cardiopulmonary Care Sciences, Georgia State University, Atlanta, Georgia

Publication date: January 1, 2006

More about this publication?
Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more